These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10422496)

  • 1. [Presence of CD markers on hematopoietic cells].
    Koubek K
    Vnitr Lek; 1998 Oct; 44(10):609-23. PubMed ID: 10422496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The CD nomenclature of leukocyte antigens].
    Koubek K
    Vnitr Lek; 2003 Jan; 49(1):66-72. PubMed ID: 12666436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematopoiesis from the aspect of CD antigen expression].
    Koubek K
    Cas Lek Cesk; 2002 Sep; 141 Suppl():5-12. PubMed ID: 12428415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD antigens 1993: an updated nomenclature for clusters of differentiation on human cells. IUIS/WHO Subcommittee on CD Nomenclature.
    IUIS/WHO Subcommittee on CD Nomenclature
    Bull World Health Organ; 1994; 72(5):807-8. PubMed ID: 7955032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 8th Human Leucocyte Differentiation Antigens Workshop: potential new CD molecules.
    Zola H;
    J Biol Regul Homeost Agents; 2002; 16(2):119-24. PubMed ID: 12144124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Human leukocyte differentiation antigens and CD classification].
    Koubek K
    Vnitr Lek; 2008 Apr; 54(4):402-9. PubMed ID: 18630620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.
    Engel P; Boumsell L; Balderas R; Bensussan A; Gattei V; Horejsi V; Jin BQ; Malavasi F; Mortari F; Schwartz-Albiez R; Stockinger H; van Zelm MC; Zola H; Clark G
    J Immunol; 2015 Nov; 195(10):4555-63. PubMed ID: 26546687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
    Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD nomenclature--a brief historical summary of the CD nomenclature, why it exists and how CDs are defined.
    Zola H
    J Biol Regul Homeost Agents; 1999; 13(4):226-8. PubMed ID: 10703947
    [No Abstract]   [Full Text] [Related]  

  • 11. [CD nomenclature].
    Eckschlager T
    Vnitr Lek; 2003 Jan; 49(1):20. PubMed ID: 12666426
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
    Smiler D; Soltan M; Albitar M
    Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD antigens 1996: updated nomenclature for clusters of differentiation on human cells. IUIS/WHO Subcommittee on CD Nomenclature.
    Bull World Health Organ; 1997; 75(4):385-7. PubMed ID: 9342899
    [No Abstract]   [Full Text] [Related]  

  • 14. CD antigens 2002.
    Mason D; André P; Bensussan A; Buckley C; Civin C; Clark E; de Haas M; Goyert S; Hadam M; Hart D; Horejsí V; Meuer S; Morrissey J; Schwartz-Albiez R; Shaw S; Simmons D; Uguccioni M; van der Schoot E; Vivier E; Zola H
    Blood; 2002 May; 99(10):3877-80. PubMed ID: 12014373
    [No Abstract]   [Full Text] [Related]  

  • 15. CD33: biochemical and biological characterization and evaluation of clinical relevance.
    Wellhausen SR; Peiper SC
    J Biol Regul Homeost Agents; 2002; 16(2):139-43. PubMed ID: 12144127
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.
    Nilsson A; de Milito A; Mowafi F; Winberg G; Björk O; Wolpert EZ; Chiodi F
    Exp Hematol; 2005 Dec; 33(12):1500-7. PubMed ID: 16338493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of some activation/proliferation markers on human thymocytes and their correlation with cell proliferation.
    Babusíková O; Ondrácková V; Prachar J; Kusenda J; Hraska V
    Neoplasma; 1999; 46(6):349-55. PubMed ID: 10732863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor receptor profile of CD34 cells in normal bone marrow, cord blood and mobilized peripheral blood.
    De Waele M; Renmans W; Asosingh K; Vander Gucht K; Van Riet I
    Eur J Haematol; 2004 Mar; 72(3):193-202. PubMed ID: 14962238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD Antigens 2001.
    Mason D; André P; Bensussan A; Buckley C; Civin C; Clark E; de Haas M; Goyert S; Hadam M; Hart D; Horejsí V; Meuer S; Morrissey J; Schwartz-Albiez R; Shaw S; Simmons D; Uguccioni M; van der Schoot E; Vivier E; Zola H
    Mod Pathol; 2002 Jan; 15(1):71-6. PubMed ID: 11796844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.